458 studies found for:    "Uveal diseases"
Show Display Options
Rank Status Study
1 Unknown  Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
2 Completed Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
Conditions: Aniridia;   Eye Abnormality;   Ocular Hypertension;   Open Angle Glaucoma
Intervention:
3 Completed Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration (ARMD)
Intervention: Drug: ranibizumab
4 Not yet recruiting An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia
Condition: Choroideremia
Intervention: Genetic: rAAV2.REP1 vector
5 Recruiting Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery
Conditions: Cataract;   Pseudoexfoliation Syndrome
Interventions: Drug: Dexamethasone+Tobramycin eye drop;   Drug: Bromfenac eye drop
6 Completed Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
Condition: Intraocular Melanoma
Intervention: Drug: nab-paclitaxel
7 Completed AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
Conditions: Acral Lentiginous Malignant Melanoma;   Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Extraocular Extension Melanoma;   Intraocular Melanoma;   Iris Melanoma;   Lentigo Maligna Malignant Melanoma;   Recurrent Melanoma;   Stage IV Intraocular Melanoma;   Stage IV Melanoma;   Superficial Spreading Malignant Melanoma
Interventions: Drug: cediranib maleate;   Other: laboratory biomarker analysis;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
8 Completed Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Drug: lomustine;   Drug: temozolomide;   Drug: thalidomide
9 Completed Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Biological: gp100 antigen;   Biological: incomplete Freund's adjuvant;   Biological: ipilimumab
10 Recruiting Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Drug: Placebo;   Drug: Dose 1 gevokizumab;   Drug: Dose 2 gevokizumab
11 Recruiting Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Iris Melanoma;   Metastatic Intraocular Melanoma;   Recurrent Intraocular Melanoma;   Stage IIIA Intraocular Melanoma;   Stage IIIB Intraocular Melanoma;   Stage IIIC Intraocular Melanoma;   Stage IV Intraocular Melanoma
Interventions: Drug: cabozantinib-s-malate;   Drug: temozolomide;   Drug: dacarbazine;   Other: laboratory biomarker analysis
12 Recruiting Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)
Condition: Behcet's Uveitis
Interventions: Drug: Gevokizumab;   Drug: Placebo
13 Completed Vitamin E to Treat Uveitis-Associated Macular Edema
Conditions: Cystoid Macular Edema;   Uveitis
Intervention: Drug: Vitamin E
14 Completed A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy
Condition: Wet Age-related Macular Degeneration
Intervention: Device: NeoVista Ophthalmic System
15 Completed PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
Condition: Age Related Macular Degeneration
Intervention:
16 Recruiting Abatacept in the Treatment of Uveitis
Condition: Uveitis
Intervention: Drug: Abatacept
17 Terminated Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis
Conditions: Sarcoid-associated Uveitis;   Ocular Sarcoidosis;   Macular Edema
Interventions: Drug: Methotrexate;   Drug: Placebo
18 Completed A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD
Condition: Neovascular Age-related Macular Degeneration
Intervention: Biological: Intravitreal injection of KH902
19 Not yet recruiting Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Conditions: Macular Edema;   Cystoid Macular Edema;   Uveal Melanoma;   Radiation Maculopathy;   Radiation Retinopathy
Interventions: Drug: Ozurdex;   Drug: Bevacizumab
20 Completed Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration
Conditions: Choroidal Neovascularization;   Retinal Pigment Epithelial Detachment
Intervention: Drug: Ranibizumab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years